CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis

Mucosal Immunology

Volumn 7, Issue 2, 2014, Pages 292-303

  Moshkovits, I ^a   Shik, D ^a   Itan, M ^a   Karo Atar, D ^a   Bernshtein, B ^b   Hershko, A Y ^c   Van Lookeren Campagne, M ^d   Munitz, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Laboratory of Allergy and Clinical Immunology Department of Medicine Herbert Center of Mast Cell Disorders   (Israel)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CMRF35 LIKE MOLECULE 1; CMRF35 LIKE MOLECULE 8; EOTAXIN; LEUKOTRIENE B4; LYMPHOCYTE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ADIPOSE TISSUE; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL METABOLISM; CHEMOTAXIS; COLON; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; CHEMOKINE CCL11; CHEMOKINE CCL24; CHEMOKINE CCL3; CHEMOTAXIS; COLON; EOSINOPHILS; HOMEOSTASIS; HUMANS; LEUKOTRIENE B4; LIGANDS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; RESPIRATORY HYPERSENSITIVITY;

EID: 84890983592     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.47     Document Type: Article

References (51)

1. Rosenberg, H.F., Dyer, K.D. & Foster, P.S. Eosinophils: Changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9-22 (2013).
2. Rothenberg, M.E. & Hogan, S.P. The eosinophil. Annu. Rev. Immunol. 24, 147-174 (2006).
3. Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243-247 (2011).
4. Jacobsen, E.A., Taranova, A.G., Lee, N.A. & Lee, J.J. Eosinophils: Singularly destructive effector cells or purveyors of immunoregulation+. J. Allergy Clin. Immunol. 119, 1313-1320 (2007).
5. Patel, V.P. et al. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 185, 1163-1172 (1997).
6. Forssmann, U. et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185, 2171-2176 (1997).
7. Shinkai, A. et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J. Immunol. 163, 1602-1610 (1999).
8. Kitaura, M. et al. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor. J. Biol. Chem. 274, 27975-27980 (1999).
9. Jose, P.J. et al. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179, 881-887 (1994).
10. Garcia-Zepeda, E.A., Rothenberg, M.E., Ownbey, R.T., Celestin, J., Leder, P. & Luster, A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2, 449-456 (1996).
11. Hogan, S.P. et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat. Immunol. 2, 353-360 (2001).
12. Pope, S.M. et al. IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108, 594-601 (2001).
13. Pope, S.M. et al. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280, 13952-13961 (2005).
14. Foster, P.S. et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179, 173-181 (2001).
15. Hogan, S.P., Mishra, A., Brandt, E.B., Foster, P.S. & Rothenberg, M.E. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc. Natl. Acad. Sci. USA 97, 6681-6686 (2000).
16. Rosenberg, H.F., Phipps, S. & Foster, P.S. Eosinophil trafficking in allergy and asthma. J. Allergy Clin. Immunol. 119, 1303-1310 (2007). (quiz 1311-1302).
17. Forbes, E. et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J. Immunol. 172, 5664-5675 (2004).
18. Bruijnzeel, P.L., Warringa, R.A., Kok, P.T., Hamelink, M.L., Kreukniet, H. & Koenderman, L. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes. J. Allergy Clin. Immunol. 92 (1 Pt 2), 159-164 (1993).
19. Huang,W.W.,Garcia-Zepeda, E.A., Sauty, A., Oettgen, H.C., Rothenberg, M.E. & Luster, A.D. Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils. J. Exp. Med. 188, 1063-1074 (1998).
20. Busse, W.W. Leukotrienes and inflammation. Am. J. Respir. Crit. Care Med. 157 (6 Pt 2), S210-S213 (1998). discussion S247-218.
21. Munitz, A. Inhibitory receptors on myeloid cells: New targets for therapy+. Pharmacol. Ther. 125, 128-137 (2010).
22. Lee, S.M., Suk, K. & Lee, W.H. Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIFmediated TLR signalling through activation of SHP and/or PI3K. Clin. Exp. Immunol. 167, 438-446 (2012).
23. Lee, S.M., Kim, E.J., Suk, K. & Lee, W.H. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase. J. Immunol. 186, 6296-6303 (2011).
24. Clark, G.J., Ju, X., Tate, C. & Hart, D.N. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 30, 209-217 (2009).
25. Izawa, K. et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity 37, 827-839 (2012).
26. Xi, H. et al. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J. Exp. Med. 207, 7-16 (2010).
27. Rothenberg, M.E. et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 inmice. Mol. Med. 2, 334-348 (1996).
28. Choi, S.C. et al. Cutting edge: Mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J. Immunol. 187, 3483-3487 (2011).
29. Fulkerson, P.C., Fischetti, C.A., McBride, M.L., Hassman, L.M., Hogan, S.P. & Rothenberg, M.E. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc. Natl. Acad. Sci. USA 103, 16418-16423 (2006).
30. Munitz, A. & Levi-Schaffer, F. Inhibitory receptors on eosinophils: A direct hit to a possible Achilles heel+. J. Allergy Clin. Immunol. 119, 1382-1387 (2007).
31. Hogan, S.P., Foster, P.S. & Rothenberg, M.E. Experimental analysis of eosinophil-associated gastrointestinal diseases. Curr. Opin. Allergy Clin. Immunol. 2, 239-248 (2002).
32. Shik, D. & Munitz, A. Regulation of allergic inflammatory responses by inhibitory receptors. Clin. Exp. Allergy 40, 700-709 (2010).
33. Zhu, D., Kepley, C.L., Zhang, K., Terada, T., Yamada, T. & Saxon, A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat.Med. 11, 446-449 (2005).
34. Tam, S.W., Demissie, S., Thomas, D. & Daeron, M. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 59, 772-780 (2004).
35. Verjan Garcia, N. et al. SIRPalpha/CD172a regulates eosinophil homeostasis. J. Immunol. 187, 2268-2277 (2011).
36. Zhang, H., Meng, F., Chu, C.L., Takai, T. & Lowell, C.A. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 22, 235-246 (2005).
37. Munitz, A., McBride, M.L., Bernstein, J.S. & Rothenberg, M.E. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 111, 5694-5703 (2008).
38. Munitz, A., Bachelet, I., Eliashar, R., Moretta, A., Moretta, L. & Levi-Schaffer, F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107, 1996-2003 (2006).
39. Fulkerson, P.C. et al. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc. Natl. Acad. Sci. USA 101, 1987-1992 (2004).
40. Martinez-Barriocanal, A., Comas-Casellas, E., Schwartz, S. Jr, Martin, M. & Sayos, J. CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J. Biol. Chem. 285, 41781-41794 (2010).
41. Ahrens, R. et al. Intestinal macrophage/epithelial cell-derived CCL11/ eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 181, 7390-7399 (2008).
42. Kim, E.J., Lee, S.M., Suk, K. & Lee,W.H. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines. Immunology 135, 226-235 (2012).
43. Peluffo, H. et al. Overexpression of the immunoreceptor CD300f has a neuroprotective role in a model of acute brain injury. Brain Pathol. 22, 318-328 (2012).
44. Chung, D.H., Humphrey, M.B., Nakamura, M.C., Ginzinger, D.G., Seaman, W.E. & Daws, M.R. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J. Immunol 171, 6541-6548 (2003).
45. Borrego, F. The CD300 molecules: An emerging family of regulators of the immune system. Blood 121, 1951-1960 (2013).
46. Simhadri, V.R., Andersen, J.F., Calvo, E., Choi, S.C., Coligan, J.E. & Borrego, F. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 119, 2799-2809 (2012).
47. Lee, J.J., Jacobsen, E.A., McGarry, M.P., Schleimer, R.P. & Lee, N.A. Eosinophils in health and disease: The LIAR hypothesis. Clin. Exp. Allergy 40, 563-575 (2010).
48. Uhm, T.G., Kim, B.S. & Chung, I.Y. Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol. Res. 4, 68-79 (2012).
49. Dyer, K.D., Moser, J.M., Czapiga, M., Siegel, S.J., Percopo, C.M. & Rosenberg, H.F. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J. Immunol. 181, 4004-4009 (2008).
50. Zigmond, E. et al. Ly6C(hi) monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076-1090 (2012).
51. Munitz, A., Bachelet, I. & Levi-Schaffer, F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J. Allergy Clin. Immunol. 118, 1082-1089 (2006).